Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

OPKO Receives FDA Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disor

firstwordpharmaMarch 23, 2017

Tag: Neurological Disorder , Orphan Drug

PharmaSources Customer Service